Virtual Bioequivalence: an update from PAGE (+TSD!) [Dissolution / BCS / IVIVC]

posted by mittyri – Russia, 2019-06-21 11:50 (625 d 10:17 ago) – Posting: # 20356
Views: 2,349

Dear All!

here's the update from the latest PAGE meeting:
  1. Model-based approach for group sequential and adaptive designs in parallel and cross-over bioequivalence studies
    AFAIK this one is the most interesting. Authors are INSERM and FDA people. But it looks like their adaptive design cannot control TIE. How come?
  2. Selection of optimal study design based on the bioequivalence simulation study in highly variable drugs
  3. An In Vitro – In Vivo Simulation Methodology for Predicting the Outcome of Bioequivalence Studies
  4. Investigation of the impact of population parameters describing gastric emptying on bioequivalence metrics

Kind regards,

Complete thread:

 Admin contact
21,371 posts in 4,463 threads, 1,496 registered users;
online 7 (0 registered, 7 guests [including 2 identified bots]).
Forum time: Sunday 22:08 UTC (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz